Average Co-Inventor Count = 3.12
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Oncomed Pharmaceuticals, Inc. (13 from 94 patents)
2. Other (1 from 832,891 patents)
3. Genentech, Inc. (1 from 3,223 patents)
4. The State University of New York (1 from 1,996 patents)
5. Health Research, Inc. (1 from 310 patents)
6. Mereo Biopharma 5, Inc. (1 from 4 patents)
18 patents:
1. 12053524 - Anti-podocalyxin antibodies and methods of using the same
2. 11512128 - VEGF/DLL4 binding agents and uses thereof
3. 11090383 - Anti-podocalyxin antibodies and methods of using the same
4. 10960088 - Macrocycles, cobalt and iron complexes of same, and methods of making and using same
5. 10730940 - VEGF/DLL4 binding agents and uses thereof
6. 9879084 - Modified immunoglobulin molecules that specifically bind human VEGF and DLL4
7. 9873726 - Methods for identifying and isolating cells expressing a polypeptide
8. 9598497 - RSPO3 binding agents and uses thereof
9. 9574009 - Polynucleotides encoding VEGF/DLL4 binding agents
10. 9422546 - Methods for identifying and isolating cells expressing a polypeptide
11. 9376488 - VEGF binding antibodies
12. 9181333 - RSPO3 binding agents and uses thereof
13. 9168300 - MET-binding agents and uses thereof
14. 9023621 - Methods for identifying and isolating cells expressing a polypeptide
15. 8945878 - Methods for identifying and isolating cells expressing a polypeptide